Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Antiangiogenic therapies: is VEGF-A inhibition alone enough?

Antiangiogenic therapies: is VEGF-A inhibition alone enough? Expert Rev Anticancer Ther. 2011 Mar; 11(3):485-96.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.